Precision and method bias of two assays for oestradiol: consequences for decisions in assisted reproduction.
Oestradiol monitoring in assisted reproduction is empirical, with no proof of benefit. Precise oestradiol estimation will be an essential pre-requisite for high quality evaluation of possible differences between combined and ultrasound-only monitoring. Objectives of the present trial were independent method comparison and bias estimation of chemiluminescent immunoassay (CLIA) versus radioimmunoassay for oestradiol. In a prospective comparison, 505 consecutive samples were split and assayed concurrently. Precision (reproducibility), relative bias and logistics were analysed and compared to manufacturers' findings. Correlation between CLIA and radioimmunoassay was excellent. Positive bias with CLIA necessitated altering decision points for therapy. Precision (reproducibility) was superior with CLIA, making it an appropriate candidate method for future randomized trials of the effectiveness of combined oestradiol/ultrasound monitoring for assisted reproduction.
D003657:Decision Making; D004958:Estradiol / Q000032:analysis*; D005260:Female; D006801:Humans; D008163:Luminescent Measurements; D008991:Monitoring, Physiologic / Q000379:methods*; D011863:Radioimmunoassay; D015203:Reproducibility of Results; D012099:Reproductive Techniques; D015983:Selection Bias